Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-Induced Interstitial Lung Diseases.
Ng N, Padilla ML, Camus P. Ng N, et al. Among authors: padilla ml. Immunol Allergy Clin North Am. 2023 May;43(2):341-357. doi: 10.1016/j.iac.2023.01.009. Epub 2023 Mar 1. Immunol Allergy Clin North Am. 2023. PMID: 37055092 Review.
Spectrum of fibrosing diffuse parenchymal lung disease.
Morgenthau AS, Padilla ML. Morgenthau AS, et al. Among authors: padilla ml. Mt Sinai J Med. 2009 Feb;76(1):2-23. doi: 10.1002/msj.20087. Mt Sinai J Med. 2009. PMID: 19170214 Free article. Review.
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
Acute exacerbations of progressive-fibrosing interstitial lung diseases.
Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, Huggins JT, Oldham JM, Padilla ML, Roman J, Shapera S. Kolb M, et al. Among authors: padilla ml. Eur Respir Rev. 2018 Dec 21;27(150):180071. doi: 10.1183/16000617.0071-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578331 Free PMC article. Review.
Concomitant Interstitial Lung Disease with Psoriasis.
Ishikawa G, Dua S, Mathur A, Acquah SO, Salvatore M, Beasley MB, Padilla ML. Ishikawa G, et al. Among authors: padilla ml. Can Respir J. 2019 Aug 25;2019:5919304. doi: 10.1155/2019/5919304. eCollection 2019. Can Respir J. 2019. PMID: 31534591 Free PMC article.
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
Maher TM, Brown KK, Kreuter M, Devaraj A, Walsh SLF, Lancaster LH, Belloli EA, Padilla M, Behr J, Goeldner RG, Tetzlaff K, Schlenker-Herceg R, Flaherty KR; INBUILD trial investigators. Maher TM, et al. Eur Respir J. 2022 Feb 3;59(2):2004587. doi: 10.1183/13993003.04587-2020. Print 2022 Feb. Eur Respir J. 2022. PMID: 34210788 Free PMC article.
101 results